Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

Delayed Quote. Delayed  - 07/29 03:52:59 pm
39.49 USD   -0.20%
07/20 Natus Medical Announces Record Second Quarter 2016 Financial Resu..
07/20 NATUS MEDICAL : beats 2Q profit forecasts
07/06 Natus Medical Acquires RetCam Ophthalmic Imaging System
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Natus Medical : Natus to Present at the Thomas Weisel Partners 2007 Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/28/2007 | 02:00pm CEST

Natus Medical Incorporated (Nasdaq:BABY) today announced that Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will make a presentation at the Thomas Weisel Partners 2007 Healthcare Conference. The conference is being held at the Four Seasons Hotel in Boston, Massachusetts. Mr. Murphy is scheduled to present at 2:05 p.m. Eastern Time (11:05 a.m. PT) on Thursday, September 6, 2007.

Investors may listen to the live webcast and view a copy of the slide presentation online via the ?Investors? section of the Company's web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days. Attendance at the Thomas Weisel Partners 2007 Healthcare Conference is by invitation only.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, Chief Financial Officer, 650-802-0400
InvestorRelations@Natus.com


© Business Wire 2007
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NATUS MEDICAL INC
07/20 Natus Medical Announces Record Second Quarter 2016 Financial Results
07/20 NATUS MEDICAL : beats 2Q profit forecasts
07/20 NATUS MEDICAL INC : Results of Operations and Financial Condition, Financial Sta..
07/06 Natus Medical Acquires RetCam Ophthalmic Imaging System
07/06 Natus Medical to Hold 2016 Second Quarter Financial Results Conference Call o..
06/29 IRADIMED CORPORATION Announces Appointment of Jonathan Kennedy to its Board o..
06/28 NATUS MEDICAL : Announces $20 Million Share Repurchase Program
06/28 NATUS MEDICAL : to Present at Jefferies 2016 Healthcare Conference
06/11 NATUS MEDICAL : $107,984 Federal Contract Awarded to Natus Medical
06/03 Natus Announces $20 Million Share Repurchase Program
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09:05aDJSony Reports Surprise Profit
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/28DJTHERMO FISHER SCIENTIFIC : Beats Expectations, Raises Outlook
07/25DJADRs End Lower; Philips Rises
07/25DJPHILIPS : Cost Savings, Strong Sales Boost Philips' Earnings
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
07/20 Natus Medical's (BABY) CEO Jim Hawkins on Q2 2016 Results - Earnings Call Tra..
07/20 Natus Medical Q2 revenues up 5%; Non-GAAP EPS up 15%; updates guidance
07/20 Natus Medical beats by $0.03, beats on revenue
07/19 Notable earnings before Wednesday?s open
06/03 Natus Medical expands share buybacks $20M
Advertisement
Financials ($)
Sales 2016 389 M
EBIT 2016 71,4 M
Net income 2016 46,9 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 27,87
P/E ratio 2017 24,43
Capi. / Sales 2016 3,37x
Capi. / Sales 2017 3,21x
Capitalization 1 310 M
More Financials
Chart NATUS MEDICAL INC
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Full-screen chart
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 45,0 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy CFO, Principal Financial & Accounting Officer, SVP
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NATUS MEDICAL INC-17.65%1 310
THERMO FISHER SCIENTIF..11.96%62 498
BOSTON SCIENTIFIC CORP..32.00%33 026
INTUITIVE SURGICAL, IN..26.35%26 564
PHILIPS1.66%25 167
ILLUMINA, INC.-13.30%24 497
More Results